Addus HomeCare (NASDAQ:ADUS) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of Addus HomeCare (NASDAQ:ADUS) from a buy rating to a hold rating in a research note published on Thursday.

A number of other equities research analysts have also weighed in on the company. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $133.67.

Addus HomeCare Trading Up 1.6 %

Shares of ADUS stock opened at $133.32 on Thursday. The firm has a fifty day simple moving average of $125.15 and a 200-day simple moving average of $126.34. The company has a market capitalization of $2.42 billion, a PE ratio of 30.51, a price-to-earnings-growth ratio of 1.63 and a beta of 1.00. Addus HomeCare has a twelve month low of $85.94 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the prior year, the company posted $1.03 EPS. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. Equities research analysts predict that Addus HomeCare will post 4.58 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Addus HomeCare in the third quarter valued at $1,622,000. Dimensional Fund Advisors LP increased its holdings in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the period. Point72 Asset Management L.P. lifted its position in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after purchasing an additional 16,997 shares during the period. Finally, American Century Companies Inc. grew its position in Addus HomeCare by 90.6% in the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after purchasing an additional 8,743 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.